Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cronos Group Inc.

Cronos Group Inc. (CRON) Stock Overview

Explore Cronos Group Inc.’s financial performance, market position, analyst ratings, and future outlook.

CRON●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$3.31
$0.02(0.61%)
U.S. Market opens in 62h 43m

Cronos Group Inc. (CRON)

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio18.15
EPS (TTM)$0.11
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$3.34
3 Months$3.26
1 Year Target$3.13

CRON Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cronos Group Inc. (NASDAQ: CRON) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Cronos Group Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CRON on the NASDAQ shows an RSI of 69.66, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.13 for the NASDAQ listing.

Key metrics behind Cronos Group Inc.'s NASDAQ-traded stock include a P/E ratio of 18.15 and a market capitalization of 1.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CRON on the NASDAQ.

Price Performance (NASDAQ: CRON)

1-Day Change
2.80%
5-Day Change
5.08%
1-Month Change
18.21%
3-Month Change
21.25%
6-Month Change
22.59%
Year-to-Date (YTD) Change
25.86%
1-Year Change
29.30%
3-Year Change
84.92%
5-Year Change
-48.12%
All-Time (Max) Change
1906.06%

Contact Information

https://www.thecronosgroup.com
14165040004
111 Peter Street, Stayner, ON, M5V 2H1

Company Facts

6,100 Employees
IPO DateFeb 27, 2018
CountryCA
Actively Trading

Frequently Asked Questions